Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Lambda Funds is a private venture capital firm based in New York that invests in niche businesses rather than operating as a drug developer, biotech company, or healthcare services company. Publicly available descriptions characterize the firm as an active VC investor founded in 1979, with a strategy focused on businesses that can become leaders in narrowly defined markets with relatively modest capital requirements. Its disclosed portfolio has included some healthcare- and life-science-adjacent investments such as PingMD, Cardialen, Health Dialog Services, and AiM Medical Robotics, alongside software and other non-healthcare companies. Because The Lambda Funds is an investor rather than a therapeutic developer, it does not have a drug pipeline, clinical stage, modalities, or biological targets of its own.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Lambda Fund.